Other at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherReconcilingItems.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s other?
- Oruka Therapeutics, Inc. (ORKA) reported other of $237.25K in Q4 2025.
- How has Oruka Therapeutics, Inc.'s other changed year-over-year?
- Oruka Therapeutics, Inc.'s other increased by 132.5% year-over-year, from -$731K to $237.25K.
- What does other mean?
- This captures miscellaneous adjustments that reconcile the federal statutory income tax rate to the actual effective tax rate. It serves as a catch-all for various non-standard tax items that do not fit into primary categories like credits or valuation allowances.